KI
SRPT icon

Kula Investments’s Sarepta Therapeutics SRPT Stock Holding History

Kula Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$459K Buy
+3,331
New +$432K 0.11% 336

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kula Investments's SRPT Position: Q1 2023 in Review

Kula Investments opened a new position in Sarepta Therapeutics (SRPT) in Q1 2023: 3,331 shares worth $459K. The stake represents 0.11% of the portfolio and ranks #336 among its holdings.

425 funds tracked by Wall St. Rank hold SRPT as of Q1 2023.

  • Kula Investments held 3,331 shares of Sarepta Therapeutics worth $459K as of Q1 2023.
  • Sarepta Therapeutics was a new Kula Investments position in Q1 2023.
  • Sarepta Therapeutics made up 0.11% of Kula Investments's portfolio in Q1 2023, its #336 holding.
  • 425 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.